The impact of obesity on subclinical coronary atherosclerosis according to the risk of cardiovascular disease

Obesity

Volumn 22, Issue 7, 2014, Pages 1762-1768

  Lee, Seung Yul ^a   Chang, Hyuk Jae ^a,b   Sung, Jimin ^c   Kim, Kwang Joon ^b,d   Shin, Sanghoon ^a   Cho, In Jeong ^a   Shim, Chi Young ^a   Hong, Geu Ru ^a   Chung, Namsik ^a  

^a Yonsei University Health System   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c CHA University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INDEPENDENT VARIABLE; INTRAABDOMINAL FAT; KOREAN (PEOPLE); LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; RISK ASSESSMENT; SMOKING; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL TO SUBCUTANEOUS FAT RATIO; WAIST CIRCUMFERENCE; ABDOMINAL FAT; AGED; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY ARTERY DISEASE; MIDDLE AGED; RADIOGRAPHY; RISK;

ABDOMINAL FAT; ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; RISK;

EID: 84903517651     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20760     Document Type: Article

References (22)

1. Wilson PF, D'Agostino RB, Sullivan L, Parise H, Kannel WB,. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-1872.
2. Han TS, Leer EMV, Seidell JC, Lean MEJ,. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311: 1401-1405.
3. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 2007; 116: 39-48.
4. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 605-613.
5. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336-1345.
6. Fox CS, Hwang SJ, Massaro JM, et al. Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study). Am J Cardiol 2009; 104: 543-547.
7. Ho JS, Cannaday JJ, Barlow CE, Willis B, Haskell WL, FitzGerald SJ,. Comparative relation of general, central, and visceral adiposity measures for coronary artery calcium in subjects without previous coronary events. Am J Cardiol 2009; 104: 943-946.
8. Ohashi N, Yamamoto H, Horiguchi J, et al. Visceral fat accumulation as a predictor of coronary artery calcium as assessed by multislice computed tomography in Japanese patients. Atherosclerosis 2009; 202: 192-199.
9. Choi S-Y, Kim D, Oh B-H, et al. General and abdominal obesity and abdominal visceral fat accumulation associated with coronary artery calcification in Korean men. Atherosclerosis 2010; 213: 273-278.
10. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
11. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008; 117: 743-753.
12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R,. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832.
13. Mahoney LT, Burns TL, Stanford W, et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine study. J Am Coll Cardiol 1996; 27: 277-284.
14. Lee CD, Jacobs DR Jr, Schreiner PJ, Iribarren C, Hankinson A,. Abdominal obesity and coronary artery calcification in young adults: the coronary artery risk development in young adults (CARDIA) study. Am J Clin Nutr 2007; 86: 48-54.
15. Kim D-J, Bergstrom J, Barrett-Connor E, Laughlin GA,. Visceral adiposity and subclinical coronary artery disease in elderly adults: Rancho Bernardo study. Obesity 2008; 16: 853-858.
16. Cassidy AE, Bielak LF, Zhou Y, et al. Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation 2005; 111: 1877-1882.
17. Klatsky AL, Armstrong MA,. Cardiovascular risk factors among Asian Americans living in Northern California. Am J Public Health 1991; 81: 1423-1428.
18. Potts J, Simmons D,. Sex and ethnic group differences in fat distribution in young United Kingdom South Asians and Europids. J Clin Epidemiol 1994; 47: 837-841.
19. Tankõ LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C,. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003; 107: 1626-1631.
20. Narumi H, Yoshida K, Hashimoto N, et al. Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening. Int J Cardiol 2009; 135: 150-155.
21. Tritos NA, Mantzoros CS,. Leptin: its role in obesity and beyond. Diabetologia 1997; 40: 1371-1379.
22. Yang X, Smith U,. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 2007; 50: 1127-1139.